Gsk (GLAXF) Revenue (2009 - 2026)

Gsk's Revenue history runs 18 years deep, the most recent figure standing at $10.3 billion for Q1 2026.

• In Q1 2026, Revenue rose 8.65% year-over-year to $10.3 billion; the TTM figure through Mar 2026 stood at $43.9 billion (down 11.06% YoY), while the FY2025 annual figure was $43.1 billion, up 7.39% from the prior year.
• Revenue was $10.3 billion for Q1 2026 at Gsk, down from $11.5 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $19.6 billion in Q4 2024 to a low of $8.4 billion in Q1 2023.
• Historically, Revenue has averaged $11.3 billion across 5 years, with a median of $10.3 billion in 2026.
• The sharpest annual moves came in 2022 and 2025: Revenue surged 73.62% in 2022, then slumped 41.42% in 2025.
• A 5-year view of Revenue shows it stood at $16.6 billion in 2022, then rose by 5.89% to $17.5 billion in 2023, then increased by 11.59% to $19.6 billion in 2024, then plunged by 41.42% to $11.5 billion in 2025, then retreated by 10.28% to $10.3 billion in 2026.
• The last three Revenue figures came in at $10.3 billion (Q1 2026), $11.5 billion (Q4 2025), and $11.5 billion (Q3 2025), per Business Quant data.